Literature DB >> 24607042

Allergy immunotherapy adherence and delivery route: location does not matter.

Linda S Cox1, Cheryl Hankin2, Richard Lockey3.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24607042     DOI： 10.1016/j.jaip.2014.01.010

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  13 in total

Review 1.  Allergen Immunotherapy and Atopic Dermatitis: the Good, the Bad, and the Unknown.

Authors:  Patrick Rizk; Mario Rodenas; Anna De Benedetto
Journal:  Curr Allergy Asthma Rep       Date:  2019-11-27       Impact factor: 4.806

2.  Sublingual immunotherapy for food allergy and its future directions.

Authors:  Stephen A Schworer; Edwin H Kim
Journal:  Immunotherapy       Date:  2020-07-02       Impact factor: 4.196

3.  New modalities of allergen immunotherapy.

Authors:  Manish Ramesh; Merhunisa Karagic
Journal:  Hum Vaccin Immunother       Date:  2018-09-14       Impact factor: 3.452

4.  Subcutaneous Allergen Immunotherapy in Children: Real Life Compliance and Effect of COVID-19 Pandemic on Compliance.

Authors:  Elif Soyak Aytekin; Özge Soyer; Bülent E Şekerel; Ümit M Şahiner
Journal:  Int Arch Allergy Immunol       Date:  2021-04-22       Impact factor: 2.749

5.  Adherence and systemic reaction rates to allergy immunotherapy among veterans.

Authors:  Joseph T Ellenburg; Jay A Lieberman; Debendra Pattanaik
Journal:  Allergy Rhinol (Providence)       Date:  2016-01-01

6.  Real-life adherence to subcutaneous immunotherapy: What has changed in the era of the COVID-19 pandemic.

Authors:  Ilkay Koca Kalkan; Hale Ates; Kurtulus Aksu; Selma Yesilkaya; Musa Topel; Dilek Cuhadar Ercelebi; Suleyman Turkyilmaz; Ali Oncul; Senay Demir
Journal:  World Allergy Organ J       Date:  2021-06-08       Impact factor: 4.084

7.  Prospective adherence to specific immunotherapy in Europe (PASTE) survey protocol.

Authors:  Melina Makatsori; Gianenrico Senna; Constantinos Pitsios; Ramon Lleonart; Ludger Klimek; Carlos Nunes; Maia Rukhadze; Barbara Rogala; Radoslaw Gawlik; Petr Panzner; Oliver Pfaar; Moises Calderon
Journal:  Clin Transl Allergy       Date:  2015-04-27       Impact factor: 5.871

8.  An accelerated dose escalation with a grass pollen allergoid is safe and well-tolerated: a randomized open label phase II trial.

Authors:  A M Chaker; B Al-Kadah; U Luther; U Neumann; M Wagenmann
Journal:  Clin Transl Allergy       Date:  2016-02-02       Impact factor: 5.871

9.  Adherence to Allergen Subcutaneous Immunotherapy is Increased by a Shortened Build-Up Phase: A Retrospective Study.

Authors:  Cristiano Caruso; Barbara Bramé; Diego Bagnasco; Alessia Cocconcelli; Valeria Ortolani; Valerio Pravettoni; Sergio Scarpa; Giuliana Zisa; Giovanni Passalacqua; Stefania Colantuono
Journal:  Biomed Res Int       Date:  2020-02-18       Impact factor: 3.411

10.  Health and Economic Outcomes of Home Maintenance Allergen Immunotherapy in Select Patients with High Health Literacy during the COVID-19 Pandemic: A Cost-Effectiveness Analysis During Exceptional Times.

Authors:  Marcus S Shaker; Giselle Mosnaim; John Oppenheimer; David Stukus; Elissa M Abrams; Matthew Greenhawt
Journal:  J Allergy Clin Immunol Pract       Date:  2020-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.